Treatment Options in Severe Eosinophilic Asthma

Insights from 2024 ATS Annual Meeting
A

ATS 2024 Insights: Reducing Short Acting Beta Agonist (SABA) Inhaler Prescription Refill Rates in Specialist Treated Asthma Patients - A Quality Improvement Initiative

By Insights from 2024 ATS Annual Meeting FEATURING Arjun Mohan
By Insights from 2024 ATS Annual Meeting FEATURING Arjun Mohan
313 views
July 8, 2024
Comments 1
Login to view comments. Click here to Login
20:20

ATS 2024 Insights: 2024 Year in Review - Precision Medicine in Asthm…

Insights from 2024 ATS Annual Meeting

T. Guilbert

748 views
26:00

Mepolizumab for Severe Eosinophilic Asthma

Stanley Goldstein

676 views
21:02

New Directions in Asthma Therapy: What Do the Guidelines Say?

University of Colorado Department of Medicine

A. Fuhlbrigge

197 views
44:41

Severe Asthma Plus: Pulmonary Hypereosinophilic Syndromes, Eosinophi…

National Jewish Health

M. Wechsler

2.4K views
23:46

Asthma Phenotypes and Endotypes

USF Health

J. Cardet

359 views
29:27

The Language of Severe Asthma

USF Health

N. C. Ramirez

905 views